NCT01699932 - Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled | Biotech Hunter

Enrollment

167

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Glimepiride+metformin (Amaryl M®) - HOE4900

"Pharmaceutical form:tablet~Route of administration: oral"

Trial Locations (13)

Investigational Site Number 804007, Vinnytsia

Investigational Site Number 804002, Vinnytsia

Investigational Site Number 804006, Poltava

Investigational Site Number 804003, Chernivtsi

Investigational Site Number 804008, Donetsk

Investigational Site Number 804004, Donetsk

Investigational Site Number 804001, Donetsk

Investigational Site Number 422-002, Beirut

Investigational Site Number 422-001, Hazmiyeh

Investigational Site Number 643-03, Saint Petersburg

Investigational Site Number 643002, Saint Petersburg

Investigational Site Number 643001, Samara

Investigational Site Number 804010, Odesa